Application of a neural network for gentamicin concentration prediction in a general hospital population

被引:21
作者
Corrigan, BW
Mayo, PR
Jamali, F
机构
[1] Fac. Pharm. and Pharmaceutical Sci., University of Alberta, Edmonton, Alta.
[2] Fac. Pharm. and Pharmaceutical Sci., University of Alberta, Edmonton
关键词
gentamicin; neural networks; therapeutic drug monitoring;
D O I
10.1097/00007691-199702000-00004
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Neural network (NN) computation is computer modeling based in part on simulation of the structure and function of the brain. These modeling techniques have been Found useful as pattern recognition tools. In the present study, data including age, sex, height, weight, serum creatinine concentration, dose, dosing interval, and rime of measurement were collected from 240 patients with various diseases being treated with gentamicin in a general hospital setting. The patient records were randomly divided into two sets: a training set of 220 patients used to develop relationships between input and output variables (peak and trough plasma concentrations) and a testing set (blinded from the NN) of 20 to test the NN. The network model was the back-propagation, feed-forward model. Various networks were tested, and the most accurate networks for peak and trough (calculated as mean percent error, root mean squared error of the testing group, and r value between observed and predicted values) were reported. The results indicate that NNs can predict gentamicin serum concentrations accurately from various input data over a range of patient ages and renal function and may offer advantages over traditional dose prediction methods for gentamicin.
引用
收藏
页码:25 / 28
页数:4
相关论文
共 16 条
[1]   A NEURAL-NETWORK TRAINED TO IDENTIFY THE PRESENCE OF MYOCARDIAL-INFARCTION BASES SOME DECISIONS ON CLINICAL ASSOCIATIONS THAT DIFFER FROM ACCEPTED CLINICAL TEACHING [J].
BAXT, WG .
MEDICAL DECISION MAKING, 1994, 14 (03) :217-222
[2]   COMPLEXITY, CHAOS AND HUMAN PHYSIOLOGY - THE JUSTIFICATION FOR NONLINEAR NEURAL COMPUTATIONAL ANALYSIS [J].
BAXT, WG .
CANCER LETTERS, 1994, 77 (2-3) :85-93
[3]   NEURAL-NETWORK PREDICTED PEAK AND TROUGH GENTAMICIN CONCENTRATIONS [J].
BRIER, ME ;
ZURADA, JM ;
ARONOFF, GR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :406-412
[4]   On the quality of neural net classifiers [J].
Egmont-Petersen, M. ;
Talmon, J.L. ;
Brender, J. ;
McNair, P. .
Artificial Intelligence in Medicine, 1994, 6 (05) :359-381
[5]   INTRODUCTION TO BACKPROPAGATION NEURAL NETWORK COMPUTATION [J].
ERB, RJ .
PHARMACEUTICAL RESEARCH, 1993, 10 (02) :165-170
[6]   PREDICTION OF THE EARLY PROGNOSIS OF THE HEPATECTOMIZED PATIENT WITH HEPATOCELLULAR-CARCINOMA WITH A NEURAL-NETWORK [J].
HAMAMOTO, I ;
OKADA, S ;
HASHIMOTO, T ;
WAKABAYASHI, H ;
MAEBA, T ;
MAETA, H .
COMPUTERS IN BIOLOGY AND MEDICINE, 1995, 25 (01) :49-59
[7]   QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS BY NEURAL NETWORKS AND INDUCTIVE LOGIC PROGRAMMING .2. THE INHIBITION OF DIHYDROFOLATE-REDUCTASE BY TRIAZINES [J].
HIRST, JD ;
KING, RD ;
STERNBERG, MJE .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1994, 8 (04) :421-432
[8]   APPLICATION OF NEURAL COMPUTING IN PHARMACEUTICAL PRODUCT DEVELOPMENT [J].
HUSSAIN, AS ;
YU, XQ ;
JOHNSON, RD .
PHARMACEUTICAL RESEARCH, 1991, 8 (10) :1248-1252
[9]   FEASIBILITY OF DEVELOPING A NEURAL NETWORK FOR PREDICTION OF HUMAN PHARMACOKINETIC PARAMETERS FROM ANIMAL DATA [J].
HUSSAIN, AS ;
JOHNSON, RD ;
VACHHARAJANI, NN ;
RITSCHEL, WA .
PHARMACEUTICAL RESEARCH, 1993, 10 (03) :466-469
[10]   USE OF NEURAL NETWORKS IN PREDICTING THE RISK OF CORONARY-ARTERY DISEASE [J].
LAPUERTA, P ;
AZEN, SP ;
LABREE, L .
COMPUTERS AND BIOMEDICAL RESEARCH, 1995, 28 (01) :38-52